Overview

Sacubitril-valsartan in Patients With Heart Failure.

Status:
RECRUITING
Trial end date:
2026-03-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and efficacy of Sacubitril -Valsartan in patients with heart failure.
Phase:
NA
Details
Lead Sponsor:
Damanhour University
Treatments:
Adrenergic beta-Antagonists
sacubitril and valsartan sodium hydrate drug combination